Barchart.com
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Pharmadrug Inc (LMLLF)

Pharmadrug Inc (LMLLF)
N/A x N/A N/A x N/A
Pre-market by (Cboe BZX)
0.0095 -0.0001 (-1.04%) 03/19/25 [OTC US]
N/A x N/A N/A x N/A
Pre-market 0.0095 unch (unch) 15:39 ET
Quote Overview for Wed, Mar 19th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Day Low
0.0095
Day High
0.0100
Open 0.0100
Previous Close 0.0096 0.0096
Volume 504,200 504,200
Avg Vol 35,070 35,070
Stochastic %K 34.07% 34.07%
Weighted Alpha -83.24 -83.24
5-Day Change -0.0025 (-20.83%) -0.0025 (-20.83%)
52-Week Range 0.0042 - 0.0400 0.0042 - 0.0400
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
 Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A
Free Barchart Webinars! Live educational sessions using site features to explore today's markets.
Get delivered to your inbox for FREE:
Sign Up.

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0070 +35.71%
on 02/26/25
Period Open: 0.0102
0.0160 -40.63%
on 02/21/25
-0.0007 (-6.86%)
since 02/19/25
3-Month
0.0065 +46.15%
on 02/06/25
Period Open: 0.0073
0.0160 -40.63%
on 02/21/25
+0.0022 (+30.14%)
since 12/19/24
52-Week
0.0042 +126.19%
on 08/01/24
Period Open: 0.0300
0.0400 -76.25%
on 08/20/24
-0.0205 (-68.33%)
since 03/19/24

Most Recent Stories

More News
PharmaDrug Announces Issuance of Debenture Units Newsfile - Fri Nov 15, 2024

Toronto, Ontario--(Newsfile Corp. - November 15, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRX.CN : 0.0150 (+50.00%)
LMLLF : 0.0095 (-1.04%)
PharmaDrug Announces Proposed Issuance of Debenture Units Newsfile - Thu Oct 31, 2024

Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRX.CN : 0.0150 (+50.00%)
LMLLF : 0.0095 (-1.04%)
PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases Newsfile - Thu Oct 31, 2024

Toronto, Ontario--(Newsfile Corp. - October 31, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRX.CN : 0.0150 (+50.00%)
LMLLF : 0.0095 (-1.04%)
PharmaDrug's Sairiyo Therapuetics Announces Initiation of Study Start-Up Activities and Design for Clinical Trial of PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases Newsfile - Thu Sep 19, 2024

Toronto, Ontario--(Newsfile Corp. - September 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug's Sairiyo Therapuetics Provides Strategic Plans to Advance PD-001 (Patented Reformulated Cepharanthine) for Viral Infectious Diseases Newsfile - Wed Aug 28, 2024

Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

PHRRF : 0.1460 (-4.26%)
LMLLF : 0.0095 (-1.04%)
PHRM.CN : 0.2100 (-4.55%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug's Sairiyo Therapuetics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins Newsfile - Wed Aug 21, 2024

Toronto, Ontario--(Newsfile Corp. - August 21, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug's Sairiyo Therapuetics Receives Approval to Initiate Phase 1 Clinical Trial of Patented Reformulated Cepharanthine Newsfile - Mon Aug 19, 2024

Toronto, Ontario--(Newsfile Corp. - August 19, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
Pharmadrug's Securedose Announces LOI with Canadian Controlled Drug Substance Licensed Dealer for Patent Pending Pharmaceutical Grade Cocaine Newsfile - Thu May 23, 2024

Toronto, Ontario--(Newsfile Corp. - May 23, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine Newsfile - Wed May 15, 2024

Toronto, Ontario--(Newsfile Corp. - May 15, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug Provides Forward Plan to Move Its Patent Pending Process and Formulation of Pharmaceutical Grade Biosynthetic Cocaine Through Development into Commercialization Newsfile - Mon May 13, 2024

Toronto, Ontario--(Newsfile Corp. - May 13, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug Announces Director Appointment and Resignation Newsfile - Thu May 2, 2024

Toronto, Ontario--(Newsfile Corp. - May 2, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine Newsfile - Wed May 1, 2024

Toronto, Ontario--(Newsfile Corp. - May 1, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug's SecureDose Announces the Advancement of Process Development of Its Biosynthetic Formulation of Pharmaceutical Grade Cocaine Newsfile - Tue Apr 16, 2024

Victoria's Chiral Labs to lead development of novel cocaine manufacturing processToronto, Ontario--(Newsfile Corp. - April 16, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug's SecureDose Announces Filing of US Provisional Patent for Manufacturing Method for Biosynthetic Pharmaceutical Grade Cocaine Newsfile - Wed Mar 13, 2024

Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC PINK: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug Appoints Current Board Member Dr. David Kideckel as Chairman Newsfile - Tue Feb 27, 2024

Toronto, Ontario--(Newsfile Corp. - February 27, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug's Sairiyo Successfully Demonstrates Ability to Manufacture Cepharanthine (PD-001) for Human Clinical Studies Newsfile - Wed Feb 14, 2024

Company to pursue regulatory filing for Phase I/II clinical studyToronto, Ontario--(Newsfile Corp. - February 14, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"),...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug Inc. Engages Investor Relations and Marketing Service Providers Newsfile - Mon Feb 12, 2024

Toronto, Ontario--(Newsfile Corp. - February 12, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), today announced that it has entered into (i) a marketing and distribution...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug Inc. Announces Successful Closing of Non-Brokered Private Placement Newsfile - Thu Feb 8, 2024

Toronto, Ontario--(Newsfile Corp. - February 8, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), is pleased to announce the closing of its previously announced non-brokered...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug Announces Share Consolidation and Change to Chief Financial Officer Newsfile - Fri Oct 20, 2023

Toronto, Ontario--(Newsfile Corp. - October 20, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), announced today that it will be proceeding with the consolidation of...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
PharmaDrug Announces Amendment to Shareholder Meeting Matter Newsfile - Tue Sep 19, 2023

Toronto, Ontario--(Newsfile Corp. - September 19, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), announced today that, further to its press release dated September...

LMLLF : 0.0095 (-1.04%)
PHRX.CN : 0.0150 (+50.00%)
More news for this symbol

Key Turning Points

Daily
52-Week
3rd Resistance Point 0.0103
2nd Resistance Point 0.0102
1st Resistance Point 0.0098
Last Price 0.0095
1st Support Level 0.0093
2nd Support Level 0.0092
3rd Support Level 0.0088

See More

52-Week High 0.0400
Fibonacci 61.8% 0.0263
Fibonacci 50% 0.0221
Fibonacci 38.2% 0.0179
Last Price 0.0095
52-Week Low 0.0042

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals
Wed, Mar 26, 2025 5:00 PM UTC
Reserve Your Spot

Info When You Need It Most.

Barchart Premier is one of the most powerful tools in the investment world. Come see why so many subscribers love it — and try it risk-free for 30 days.

Start 30-Day Risk Free Trial